Jinhe Biotechnology Co (SZSE:002688) Total Liabilities : ¥3,060 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Total Liabilities?

Jinhe Biotechnology Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥3,060 Mil.

Jinhe Biotechnology Co's quarterly Total Liabilities increased from Sep. 2023 (¥2,803.49 Mil) to Dec. 2023 (¥2,937.13 Mil) and increased from Dec. 2023 (¥2,937.13 Mil) to Mar. 2024 (¥3,060.29 Mil).

Jinhe Biotechnology Co's annual Total Liabilities increased from Dec. 2021 (¥1,368.03 Mil) to Dec. 2022 (¥2,083.22 Mil) and increased from Dec. 2022 (¥2,083.22 Mil) to Dec. 2023 (¥2,937.13 Mil).

Jinhe Biotechnology Co Total Liabilities Historical Data

The historical data trend for Jinhe Biotechnology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Total Liabilities Chart

Jinhe Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,537.40

1,628.79

1,368.03

2,083.22

2,937.13

Jinhe Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,112.80	2,539.20	2,803.49	2,937.13	3,060.29

Jinhe Biotechnology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jinhe Biotechnology Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2257.325	+	(523.68	+	156.121
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,937

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	5453.807	-	2516.681
	=	2,937

Jinhe Biotechnology Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2099.03	+	(803.799	+	157.462
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,060

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	5589.5	-	2529.209
	=	3,060

Jinhe Biotechnology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhe Biotechnology Co (SZSE:002688) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023

Website

http://www.jinhe.com.cn

Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.

Executives

Wang Zhi Jun	Directors, executives
Liu Ying Chun	Executives
Deng Yi Xin	Secretary Dong
Li Fu Zhong	Director
Liu Yun Tian	Directors, executives
Xie Chang Xian	Directors, executives
Wang Dong Xiao	Director
Yao Jian Xiong	Supervisors
Zheng Liu Ji	Supervisors
Niu You Shan	Executives
Wu Ming Xia	Director
Li Wei Qi	Directors, executives
Wu Rui Gang	Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines